Covered recipient · General Payments record
MERHUNISA KARAGIC
Allopathic & Osteopathic Physicians Internal Medicine Allergy & Immunology
General Payments · PY2018–2021
$465.53
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.29 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $56.84 | 2 |
| Kaleo, Inc. | $42.06 | 2 |
| GENZYME CORPORATION | $26.71 | 2 |
| Amgen Inc. | $23.25 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.22 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $29.74 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 850424799 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $27.10 | 08/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 850423903 | CMS |
| Amgen Inc. | $23.25 | 08/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826535971 | CMS |
| GENZYME CORPORATION | $13.85 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843644363 | CMS |
| GENZYME CORPORATION | $12.86 | 07/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 843644379 | CMS |
| kaleo, Inc. | $22.08 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832120889 | CMS |
| kaleo, Inc. | $19.98 | 08/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832120891 | CMS |
| Novartis Pharmaceuticals Corporation | $21.22 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812741805 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 08/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820008021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.